Source: BioPortfolio

Cempra: Cempra Inc CEMP Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 14112017 Prices from USD $250

SummaryCempra Inc Cempra formerly Cempra Holdings LLC is a pharmaceutical company that develops antibacterials to the critical medical needs. The company offers products which include solithromycin and fusidic acid. It offers solithromycin an oral and intr...

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
David Zaccardelli's photo - Interim-CEO of Cempra

Interim-CEO

David Zaccardelli

CEO Approval Rating

72/100

Read more